Vivani Medical (NASDAQ:VANI – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter.
Vivani Medical Stock Up 0.9 %
Shares of Vivani Medical stock opened at $1.10 on Tuesday. The company has a market cap of $65.16 million, a PE ratio of -2.44 and a beta of 3.20. Vivani Medical has a 52 week low of $1.03 and a 52 week high of $2.22. The business has a 50 day moving average price of $1.16 and a 200-day moving average price of $1.22.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reissued a “buy” rating and issued a $4.00 price objective on shares of Vivani Medical in a research note on Thursday, March 13th.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Further Reading
- Five stocks we like better than Vivani Medical
- Insider Trading – What You Need to Know
- Can TikTok Stock Picks Really Make You Rich?
- Best Stocks Under $5.00
- The “Quality” Rotation: Back to Basics Investing
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
